The Microbiome Sequencing Services Market in terms of revenue was estimated to be worth $284 million in 2022 and is poised to reach $555 million by 2028, growing at a CAGR of 14.3% from 2022 to 2028 according to a new report by MarketsandMarkets™. Key driving factors of the microbiome sequencing services market growth include, expanding applications for metagenomic sequencing, high focus on development of human microbiome therapeutics, and high costs associated with sophisticated sequencing instruments. In recent years, there has been a significant increase in the demand for metagenomic sequencing in the field of microbiome research owing it its wide array of applications, such as disease diagnosis, drug discovery, and precision medicine. This is expected to boost the market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380
Browse in-depth TOC on “Microbiome Sequencing Services Market”
186 – Tables
35 – Figures
200 – Pages
The sequencing and library preparation services segment accounted for the largest share of the microbiome sequencing services market in 2022
Based on service, the microbiome sequencing services market is segmented into sample preparation services, sequencing and library preparation services, and data analysis services. Sequencing and library preparation services are expected to dominate market through the forecast period. This segment includes sequencing and library preparation services for samples subjected to microbiome sequencing. This is a crucial step in microbiome analysis, wherein either reference sequences are created for samples or sequencing outputs are compared against the existing sequences.
The shotgun sequencing segment is expected to grow at the highest CAGR from 2023 to 2028
Based on type, the global microbiome sequencing services market is segmented into amplicon sequencing, whole-genome sequencing, shotgun sequencing, and other types. Advancements in data analysis solutions is expected to drive the adoption of shotgun sequencing, rendering this segment with a highest growth rate. Shotgun sequencing is a relatively new approach used to analyze many organisms present in a given complex sample and comprehensively sequence all genes.
The academic and research institutes segment accounted for the largest share of the global microbiome sequencing services market in 2022
Based on end user, the global microbiome sequencing services market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and other end users. Expanding applications of microbiome research is expected to drive the growth of academic and research institutes end user segment. This segment is inclusive of the application of microbiome sequencing services in environmental and ecological research, veterinary research, and other research activities conducted by academic and research institutes.
North America dominates the global microbiome sequencing services market throughout the forecast period
The microbiome sequencing services market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the largest share in the microbiome sequencing services market, which is attributed to the established research infrastructure, technological advancements, and demand for precision medicine. There has been a growing recognition of the role of the microbiome in various conditions, including gastrointestinal disorders, metabolic diseases, neurodegenerative diseases, and immune-related disorders. This increased awareness has led to a rising demand for microbiome sequencing services to better understand the complex interactions between the human microbiome and host health, as well as to develop targeted interventions and therapies in turn contributing to the regional revenue growth.
Microbiome Sequencing Services Market Dynamics:
Drivers:
- Increased Focus on Human Microbiome Therapy
- Human Microbiome as New Validated Target for Drug Development
- Human Microbiome for Early Disease Detection and Diagnosis
Restraints:
- Lack of Expertise and Detailed Research
- Barriers in Proving the Causal Link Between Dysbiosis and Disease
Opportunities:
- Investigational New Drug (IND) Requirements for Fecal Microbiota
- Increasing Collaborations Create Growth Opportunities
Challenges:
- Government Regulations
Burning Issues
- Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
- Development of Human Microbiome Therapeutic Products
Key Market Players:
The microbiome sequencing services market is fragmented in nature with a large pool of local service providers/emerging players operating in this market. Some of the prominent market players include Charles River Laboratories (US), Eurofins Scientific (France), BGI (China), CosmosID (US), Microba (Australia), QIAGEN (Germany), Microbiome Insights (Canada), BaseClear (Netherlands), CD Genomics (US), Zymo Research (US), OraSure Technologies (US), MR DNA (US), Eremid Genomic Services (US), Clinical-Microbiomics A/S (Denmark), Novogene Co., Ltd. (China), EzBiome (US), Boster Biological Technology (US), Zifo (India), omics2view.consulting GbR (Germany), and Macrogen, Inc. (South Korea).
Recent Developments:
- In March 2023, Microba launched a new human gut microbiome testing service for comprehensive gastrointestinal testing solutions. The solutions are accessible to healthcare professionals in Australia through a different brand name, Co-Biome.
- In February 2023, Locus Biosciences announced a long-term partnership with CosmosID to gain the support of the latter for clinical trial studies. CosmosID’s support for microbiome analysis is expected to assist Locus Biosciences in strengthening its precision therapeutics platform.
- In March 2022, Diversigen announced the launch of a new service, metatranscriptomic sequencing and analysis of the gut microbiome. This service will assist research professionals in understanding gene expression while gaining insights into both function and mechanism of microbiomes in samples.
Get Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94324380
Microbiome Sequencing Services Market Advantages:
- Comprehensive Analysis: Microbiome sequencing services offer comprehensive analysis of the microbial communities present in various sample types, providing detailed insights into their composition, diversity, and function. This allows researchers to understand the role of the microbiome in health and disease.
- High-throughput and Cost-effective: Next-generation sequencing technologies have significantly increased the throughput of microbiome sequencing, allowing for the analysis of large sample sizes in a shorter time frame. This scalability, coupled with cost-effective sequencing platforms, enables researchers to generate extensive microbiome data at a reasonable cost.
- Customized Solutions: Microbiome sequencing service providers offer tailored solutions to meet the specific needs of researchers. They provide a range of sequencing platforms, library preparation protocols, and bioinformatics analysis tools, allowing researchers to design experiments and obtain insights that align with their research objectives.
- Expertise and Infrastructure: Microbiome sequencing service providers possess specialized expertise and infrastructure dedicated to handling and processing microbiome samples. They have streamlined protocols and quality control measures in place to ensure accurate and reproducible results.
- Data Interpretation and Analysis: Microbiome sequencing services often include comprehensive bioinformatics analysis, utilizing advanced algorithms and databases to interpret and extract meaningful information from the generated data. This allows researchers to gain valuable insights into the microbiome composition, functional potential, and interactions with the host.
- Collaboration Opportunities: Microbiome sequencing services foster collaborations between researchers, clinicians, and industry stakeholders. By outsourcing the sequencing and analysis tasks to specialized service providers, researchers can focus on their core expertise while leveraging the expertise and resources of the service providers.
- Translational Applications: The insights gained from microbiome sequencing services have broad translational applications in various fields, including personalized medicine, drug discovery and development, agriculture, and environmental studies. By understanding the role of the microbiome in different contexts, researchers can develop targeted interventions and therapies for various diseases and conditions.
Related News & Articles:
https://www.marketsandmarkets.com/PressReleases/microbiome-sequencing-service.asp
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Market HighlightsIt is estimated that the global microbiome sequencing services market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2023, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7532 The global microbiome sequencing services market is currently dominated by many market players.
For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
It is a cloud-based solution used for genomic data storage and analysis of samples.Regional AnalysisThe market in the Americas is expected to dominate the global microbiome sequencing services market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region.
These factors are expected to have a positive impact on the microbiome sequencing services market.
Microbiome Sequencing Services Market Research Report: by Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Others), Application (Gastrointestinal Diseases, Infectious Diseases, Others), and End User - Forecast till 2027Market HighlightsIt is estimated that the global microbiome sequencing services market is expected to register a CAGR ~ 19.22% during the forecast period of 2018–2023, with an estimated market value of USD 555.1 million in 2017.Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market.
Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market.
For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.However, the lack of skilled technicians, and ethical and legal issues related to genome sequencing, and unaffordability of microbiome sequencing services in certain economies is expected to curb the growth of microbiome sequencing services market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7532 The global microbiome sequencing services market is currently dominated by many market players.
For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator.
This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut.
It is a cloud-based solution used for genomic data storage and analysis of samples.Regional AnalysisThe market in the Americas is expected to dominate the global microbiome sequencing services market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region.
